February 18, 2019 Licensing, IP, and Legal PR/Corporate

Brooks Automation to Participate in the Morgan Stanley Technology, Media and Telecom Investor Conference

Brooks Automation to Participate in the Morgan Stanley Technology, Media and Telecom Investor Conference CHELMSFORD, Mass., Feb. 18, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that company management will participate in the Morgan Stanley Technology, Media and Telecom Investor Conference at the Palace Hotel in San Francisco on Monday, February 25 at 5:15... Read more

February 14, 2019 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools Product Launch

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response

Date: 02/14/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug... Read more

February 12, 2019 Licensing, IP, and Legal Life Science Tools

Oxford Nanopore prevails against PacBio in decision by US Court of Appeal that upholds ITC ruling

Tue 12th February 2019 – Decision defeats attempts by PacBio to prevent Oxford Nanopore from selling its technology in the US – Oxford Nanopore announces that the US Court of Appeals for the Federal Circuit today upheld the decision of the International Trade Commission (ITC) in favour of Oxford Nanopore. In a complaint previously filed... Read more

February 4, 2019 Acad, Gov/Utilities Clinical Research/Diagn. Licensing, IP, and Legal M&A, Partnerships

GE Healthcare and Aga Khan University Hospital Pakistan announce strategic partnership

Dubai, UAE; January 29, 2019: On the sidelines of Arab Health 2019, the region’s leading healthcare exhibition, GE Healthcare and The Aga Khan University Hospital (AKUH) in Karachi, Pakistan, today announced a strategic partnership to give Pakistan’s leading private quaternary care hospital access to a new range of advanced medical imaging and diagnostic equipment. GE... Read more

January 29, 2019 Licensing, IP, and Legal Life Science Tools

Promega Corporation Enters License Agreement with Broad Institute to Access CRISPR-Cas9 Gene Editing Technology

Promega Corporation announced today it has signed a non-exclusive license agreement with the Broad Institute of MIT and Harvard to sell tools and reagents for CRISPR-Cas9 gene editing, providing scientists new tools for interrogating endogenous biology. Under the agreement, Promega will combine CRISPR-Cas9 technology with its products that knock-in Promega genetic reporters to the genomes of... Read more

January 22, 2019 Licensing, IP, and Legal Life Science Tools

Oxford Nanopore Prevails in Patent Ruling against Pacific Biosciences

January 22, 2019 09:04 AM Pacific Standard Time OXFORD, England–(BUSINESS WIRE)–Today the European Patent Office revoked Pacific Biosciences patent EP3045542 with claims to a single molecule sequencing process wherein two strands of DNA are linked by a connecting nucleic acid. The validity of the patent had been challenged by Oxford Nanopore. The EPO ruled that... Read more

January 17, 2019 Clinical Research/Diagn. Licensing, IP, and Legal Microscopy

Miltenyi Biotec acquires promising non-harmful imaging process

BERGISCH GLADBACH,  Jan 17, 2019 – Miltenyi Biotec GmbH, a global provider of products and services for biomedical research and cellular therapy, announced that it has signed a purchase contract for a non-harmful, fluorescence-preserving, optical clearing process from the University of Duisburg-Essen, Germany. The acquired invention involves an easy-to-use protocol that allows a safe optical clearing... Read more

January 7, 2019 Licensing, IP, and Legal Life Science Tools

Swift Biosciences Announces ISO 13485:2016 Certification

Ann Arbor, Michigan (January 7, 2019) – Swift Biosciences, Inc. a manufacturer of precision next-generation sequencing (NGS) solutions, announces it has received International Organization Standardization (ISO) 13485:2016 certification for design, development, production, and distribution of molecular biology and related reagents in both standard and custom formats has been assessed and approved by National Quality assurance,... Read more